What does EF EQUINE LAMENESS INVESTIGATION & PARTNERS do?

EF EQUINE LAMENESS INVESTIGATION & PARTNERS is a veterinary practice in Lasne. Private Limited, started on 23 December 2008, 1 establishment.

What is the address of EF EQUINE LAMENESS INVESTIGATION & PARTNERS?

The registered office of EF EQUINE LAMENESS INVESTIGATION & PARTNERS is located at Chaussée de Louvain 435, 1380 Lasne.

Is EF EQUINE LAMENESS INVESTIGATION & PARTNERS still active?

Yes. According to the CBE (18 September 2026) EF EQUINE LAMENESS INVESTIGATION & PARTNERS is active, legal situation “Normale toestand”, started on 23 December 2008.

Is EF EQUINE LAMENESS INVESTIGATION & PARTNERS registered on Peppol?

Yes, EF EQUINE LAMENESS INVESTIGATION & PARTNERS is registered on the Peppol network with ID 0208:0808794710.

What is the enterprise number of EF EQUINE LAMENESS INVESTIGATION & PARTNERS?

The enterprise number of EF EQUINE LAMENESS INVESTIGATION & PARTNERS is BE0808794710.

When was EF EQUINE LAMENESS INVESTIGATION & PARTNERS founded?

EF EQUINE LAMENESS INVESTIGATION & PARTNERS was founded on 23 December 2008.

Who are the directors of EF EQUINE LAMENESS INVESTIGATION & PARTNERS?

According to the 2025 annual accounts, the directors of EF EQUINE LAMENESS INVESTIGATION & PARTNERS are: ECG Ambulatory Care, Eduardo Felix SRL.

Is EF EQUINE LAMENESS INVESTIGATION & PARTNERS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did EF EQUINE LAMENESS INVESTIGATION & PARTNERS make in 2025?

EF EQUINE LAMENESS INVESTIGATION & PARTNERS posted a profit after taxes of € 450,083 in financial year 2025.

What is the revenue of EF EQUINE LAMENESS INVESTIGATION & PARTNERS?

In its most recent annual accounts (2025), EF EQUINE LAMENESS INVESTIGATION & PARTNERS reported revenue of € 1,750,641.

EF EQUINE LAMENESS INVESTIGATION & PARTNERS (Private Limited)

Dossier EF EQUINE LAMENESS INVESTIGATION & PARTNERS, printed on 18 September 2026 from databakkes.be/en/0808794710/ef-equine-lameness-investigation-partners. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

28 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

EF EQUINE LAMENESS INVESTIGATION & PARTNERS from Lasne, company number BE0808794710, closed financial year 2025 with a result of € 450,083 after tax. For that financial year EF EQUINE LAMENESS INVESTIGATION & PARTNERS recorded revenue of € 1.8 million and equity of € 331,153. Compared with financial year 2024, the result moved from € 422,557 to € 450,083. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 331,153

▲ € 250,083 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 450,083

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 223,626

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 200,000 paid out

44 % of the profit went to the shareholders, mostly to ECG Ambulatory Care (100 % of the shares). That is where the money ends up.

People and assets in 2025

Vehicles and equipment

€ 15,305

▼ 26% vs 2024

Of which on lease € 14,364.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 14,936

▼ 24% vs 2024

€ 5,054 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 164,210

▲ 159% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 30,000

▲ € 28,927 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 1,847,227 Revenue 2024: € 1,847,227 First fiscal year in the series	€ 1,750,641 Revenue 2025: € 1,750,641 ▼ 5% vs 2024 (€ 1,847,227) Unfavourable step	▼ 5%
Gross margin	€ 690,760 Gross margin 2022: € 690,760 First fiscal year in the series	€ 659,487 Gross margin 2023: € 659,487 ▼ 5% vs 2022 (€ 690,760) Unfavourable step	€ 608,872 Gross margin 2024: € 608,872 ▼ 8% vs 2023 (€ 659,487) Unfavourable step	€ 639,028 Gross margin 2025: € 639,028 ▲ 5% vs 2024 (€ 608,872) Favourable step	▲ 5%
Profit after taxes	€ 493,914 Profit after taxes 2022: € 493,914 First fiscal year in the series	€ 472,373 Profit after taxes 2023: € 472,373 ▼ 4% vs 2022 (€ 493,914) Unfavourable step	€ 422,557 Profit after taxes 2024: € 422,557 ▼ 11% vs 2023 (€ 472,373) Unfavourable step	€ 450,083 Profit after taxes 2025: € 450,083 ▲ 7% vs 2024 (€ 422,557) Favourable step	▲ 7%
Equity	€ 56,140 Equity 2022: € 56,140 First fiscal year in the series	€ 78,514 Equity 2023: € 78,514 ▲ 40% vs 2022 (€ 56,140) Favourable step	€ 81,070 Equity 2024: € 81,070 ▲ 3% vs 2023 (€ 78,514) Favourable step	€ 331,153 Equity 2025: € 331,153 ▲ € 250,083 vs 2024 (€ 81,070) Favourable step	▲ € 250,083
Total debts	€ 1,656,507 Total debts 2022: € 1,656,507 First fiscal year in the series	€ 699,906 Total debts 2023: € 699,906 ▼ 58% vs 2022 (€ 1,656,507) Favourable step	€ 506,866 Total debts 2024: € 506,866 ▼ 28% vs 2023 (€ 699,906) Favourable step	€ 420,158 Total debts 2025: € 420,158 ▼ 17% vs 2024 (€ 506,866) Favourable step	▼ 17%
Cash	€ 790,749 Cash 2022: € 790,749 First fiscal year in the series	€ 253,688 Cash 2023: € 253,688 ▼ 68% vs 2022 (€ 790,749) Unfavourable step	€ 238,336 Cash 2024: € 238,336 ▼ 6% vs 2023 (€ 253,688) Unfavourable step	€ 223,626 Cash 2025: € 223,626 ▼ 6% vs 2024 (€ 238,336) Unfavourable step	▼ 6%
Retained profit	€ 43,740 Retained profit 2022: € 43,740 First fiscal year in the series	€ 66,114 Retained profit 2023: € 66,114 ▲ 51% vs 2022 (€ 43,740) Favourable step	€ 68,670 Retained profit 2024: € 68,670 ▲ 4% vs 2023 (€ 66,114) Favourable step	€ 318,753 Retained profit 2025: € 318,753 ▲ € 250,083 vs 2024 (€ 68,670) Favourable step	▲ € 250,083
Dividend	€ 1,300,000 Dividend 2022: € 1,300,000 First fiscal year in the series	€ 450,000 Dividend 2023: € 450,000 ▼ 65% vs 2022 (€ 1,300,000) Unchanged	€ 420,000 Dividend 2024: € 420,000 ▼ 7% vs 2023 (€ 450,000) Unchanged	€ 200,000 Dividend 2025: € 200,000 ▼ 52% vs 2024 (€ 420,000) Unchanged	▼ 52%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 24,381 Bank debt 2023: € 24,381 Unchanged (€ 0) Unfavourable step	€ 19,766 Bank debt 2024: € 19,766 ▼ 19% vs 2023 (€ 24,381) Favourable step	€ 14,936 Bank debt 2025: € 14,936 ▼ 24% vs 2024 (€ 19,766) Favourable step	▼ 24%
Balance sheet total	€ 1,712,647 Balance sheet total 2022: € 1,712,647 First fiscal year in the series	€ 778,420 Balance sheet total 2023: € 778,420 ▼ 55% vs 2022 (€ 1,712,647) Unchanged	€ 587,937 Balance sheet total 2024: € 587,937 ▼ 24% vs 2023 (€ 778,420) Unchanged	€ 751,311 Balance sheet total 2025: € 751,311 ▲ 28% vs 2024 (€ 587,937) Unchanged	▲ 28%

Key figures of EF EQUINE LAMENESS INVESTIGATION & PARTNERS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EF EQUINE LAMENESS INVESTIGATION & PARTNERS?

What happened at EF EQUINE LAMENESS INVESTIGATION & PARTNERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 450,083 (▲ 7% vs 2024). Source: NBB ↗
2022 ECG Ambulatory Care became a director. NBB
2022 Eduardo Felix SRL became a director. NBB
Jan 1, 2009 New establishment in Lasne. KBO
Dec 23, 2008 Start of the company according to the CBE. KBO

In short

From € 493,914 profit in 2022 to € 450,083 profit in 2025.

Paid € 616,433 in corporate taxes since 2022.

Best year ever: 2022, with € 493,914 profit.

Paid out € 2.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at EF EQUINE LAMENESS INVESTIGATION & PARTNERS? We notify you, reason included.

Follow EF EQUINE LAMENESS INVESTIGATION & PARTNERS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit